EUVIMEDEUVIMED entdecken
Crossref

Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency

Takuya Murata, Genta Ito, Naoko Utsunomiya-Tate

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.02.073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Takuya Murata und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau, a microtubule-binding protein, is a major component of neurofibrillary tangles in the brains of Alzheimer's disease patients. Tau aggregation following fibril formation induces Alzheimer's disease pathogenesis. The accumulation of D-isomerized amino acids in proteins that occurs in several tissues with aging is thought to be implicated in age-related diseases. D-isomerized Asp accumulation has also been found in Tau in neurofibrillary tangles. We previously demonstrated the effects of D-isomerization of Asp within microtubule-binding repeat peptides of Tau, Tau R2, and R3 on the rates of structural transition and fibril formation. Here, we investigated the potency of Tau aggregation inhibitors on fibril formation of wild-type Tau R2 and R3 peptides and D-isomerized Asp-containing Tau R2 and R3 peptides. D-isomerization of Asp within Tau R2 and R3 peptides attenuated the potency of inhibitors. We next investigated the fibril morphology of D-isomerized Asp-containing Tau R2 and R3 peptides by electron microscopy. D-isomerized Asp-containing Tau R2 and R3 fibrils showed significantly different fibril morphology from that of wild-type peptides. Our results indicate that D-isomerization of Asp within Tau R2 and R3 peptides affects fibril morphology, resulting in attenuation of the potency of Tau aggregation inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmino AcidsAmino Acid Sequencetau ProteinsIsomerismPeptides

Stichwörter der Autor:innen

Aggregation inhibitorD-isomerizationFibril morphologyMicrotubule-binding repeat domainTau

Substanzen

Amino Acidstau ProteinsPeptides

Autor:innen und Institutionen

  • Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.
  • Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. Electronic address: tate@pharm.teikyo-u.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Murata, T., Ito, G., & Utsunomiya-Tate, N. (2023). Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.02.073

Vancouver

Murata T, Ito G, Utsunomiya-Tate N. Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.02.073

BibTeX
@article{Murata2023,
  author = {Murata, Takuya and Ito, Genta and Utsunomiya-Tate, Naoko},
  title = {Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.02.073}
}
Kostenlos starten →